| Parameter . | OPCAB (n = 526) . | ONCABG (n = 186) . | OR . | CI 95% . | P-value . | PA OR . | PA CI 95% . | PA P-value . |
|---|---|---|---|---|---|---|---|---|
| Mortality (%) | 1.5 | 2.2 | 0.70 | 0.20–2.36 | 0.56 | 0.16 | 0.03–0.78 | 0.02 |
| Cerebrovascular accident (CVA) (%) | 1.0 | 2.7 | 0.34 | 0.09–1.21 | 0.09 | 0.22 | 0.04–1.05 | 0.06 |
| Myocardial infarction (%) | 1.4 | 2.2 | 0.63 | 0.16–2.38 | 0.50 | 0.77 | 0.14–4.14 | 0.76 |
| Bleeding (%) | 5.5 | 3.8 | 1.49 | 0.64–3.42 | 0.35 | 0.76 | 0.28–2.30 | 0.66 |
| Renal dysfunction (%) | 3.4 | 2.7 | 1.28 | 0.46–3.50 | 0.62 | 0.78 | 0.23–2.61 | 0.69 |
| Respiratory failure (%) | 1.9 | 3.4 | 0.54 | 0.16–1.82 | 0.33 | 0.34 | 0.07–1.67 | 0.18 |
| Pleural effusions/pneumothorax (%) | 1.9 | 4.6 | 0.40 | 0.14–1.14 | 0.09 | 0.36 | 0.10–1.22 | 0.10 |
| Sinus rhythm (%) | 94.2 | 96.2 | 0.63 | 0.26–1.53 | 0.31 | 1.25 | 0.44–3.54 | 0.66 |
| Atrial fibrillation (%) | 4.4 | 3.8 | 1.17 | 0.47–2.91 | 0.72 | 0.67 | 0.22–1.98 | 0.47 |
| MACCE (CVA/MI/mortality) (%) | 3.0 | 7.0 | 0.41 | 0.19–0.88 | 0.02 | 0.24 | 0.08–0.66 | 0.006 |
| Parameter . | OPCAB (n = 526) . | ONCABG (n = 186) . | OR . | CI 95% . | P-value . | PA OR . | PA CI 95% . | PA P-value . |
|---|---|---|---|---|---|---|---|---|
| Mortality (%) | 1.5 | 2.2 | 0.70 | 0.20–2.36 | 0.56 | 0.16 | 0.03–0.78 | 0.02 |
| Cerebrovascular accident (CVA) (%) | 1.0 | 2.7 | 0.34 | 0.09–1.21 | 0.09 | 0.22 | 0.04–1.05 | 0.06 |
| Myocardial infarction (%) | 1.4 | 2.2 | 0.63 | 0.16–2.38 | 0.50 | 0.77 | 0.14–4.14 | 0.76 |
| Bleeding (%) | 5.5 | 3.8 | 1.49 | 0.64–3.42 | 0.35 | 0.76 | 0.28–2.30 | 0.66 |
| Renal dysfunction (%) | 3.4 | 2.7 | 1.28 | 0.46–3.50 | 0.62 | 0.78 | 0.23–2.61 | 0.69 |
| Respiratory failure (%) | 1.9 | 3.4 | 0.54 | 0.16–1.82 | 0.33 | 0.34 | 0.07–1.67 | 0.18 |
| Pleural effusions/pneumothorax (%) | 1.9 | 4.6 | 0.40 | 0.14–1.14 | 0.09 | 0.36 | 0.10–1.22 | 0.10 |
| Sinus rhythm (%) | 94.2 | 96.2 | 0.63 | 0.26–1.53 | 0.31 | 1.25 | 0.44–3.54 | 0.66 |
| Atrial fibrillation (%) | 4.4 | 3.8 | 1.17 | 0.47–2.91 | 0.72 | 0.67 | 0.22–1.98 | 0.47 |
| MACCE (CVA/MI/mortality) (%) | 3.0 | 7.0 | 0.41 | 0.19–0.88 | 0.02 | 0.24 | 0.08–0.66 | 0.006 |
OR: odds ratio; CI 95%: confidence interval 95%; PAOR: propensity-adjusted OR; PA CI 95%: propensity-adjusted CI 95%; PA P-value: propensity-adjusted P-value; IABP: intra-aortic balloon pump; MACCE: major adverse cardiac and cerebrovascular events.
| Parameter . | OPCAB (n = 526) . | ONCABG (n = 186) . | OR . | CI 95% . | P-value . | PA OR . | PA CI 95% . | PA P-value . |
|---|---|---|---|---|---|---|---|---|
| Mortality (%) | 1.5 | 2.2 | 0.70 | 0.20–2.36 | 0.56 | 0.16 | 0.03–0.78 | 0.02 |
| Cerebrovascular accident (CVA) (%) | 1.0 | 2.7 | 0.34 | 0.09–1.21 | 0.09 | 0.22 | 0.04–1.05 | 0.06 |
| Myocardial infarction (%) | 1.4 | 2.2 | 0.63 | 0.16–2.38 | 0.50 | 0.77 | 0.14–4.14 | 0.76 |
| Bleeding (%) | 5.5 | 3.8 | 1.49 | 0.64–3.42 | 0.35 | 0.76 | 0.28–2.30 | 0.66 |
| Renal dysfunction (%) | 3.4 | 2.7 | 1.28 | 0.46–3.50 | 0.62 | 0.78 | 0.23–2.61 | 0.69 |
| Respiratory failure (%) | 1.9 | 3.4 | 0.54 | 0.16–1.82 | 0.33 | 0.34 | 0.07–1.67 | 0.18 |
| Pleural effusions/pneumothorax (%) | 1.9 | 4.6 | 0.40 | 0.14–1.14 | 0.09 | 0.36 | 0.10–1.22 | 0.10 |
| Sinus rhythm (%) | 94.2 | 96.2 | 0.63 | 0.26–1.53 | 0.31 | 1.25 | 0.44–3.54 | 0.66 |
| Atrial fibrillation (%) | 4.4 | 3.8 | 1.17 | 0.47–2.91 | 0.72 | 0.67 | 0.22–1.98 | 0.47 |
| MACCE (CVA/MI/mortality) (%) | 3.0 | 7.0 | 0.41 | 0.19–0.88 | 0.02 | 0.24 | 0.08–0.66 | 0.006 |
| Parameter . | OPCAB (n = 526) . | ONCABG (n = 186) . | OR . | CI 95% . | P-value . | PA OR . | PA CI 95% . | PA P-value . |
|---|---|---|---|---|---|---|---|---|
| Mortality (%) | 1.5 | 2.2 | 0.70 | 0.20–2.36 | 0.56 | 0.16 | 0.03–0.78 | 0.02 |
| Cerebrovascular accident (CVA) (%) | 1.0 | 2.7 | 0.34 | 0.09–1.21 | 0.09 | 0.22 | 0.04–1.05 | 0.06 |
| Myocardial infarction (%) | 1.4 | 2.2 | 0.63 | 0.16–2.38 | 0.50 | 0.77 | 0.14–4.14 | 0.76 |
| Bleeding (%) | 5.5 | 3.8 | 1.49 | 0.64–3.42 | 0.35 | 0.76 | 0.28–2.30 | 0.66 |
| Renal dysfunction (%) | 3.4 | 2.7 | 1.28 | 0.46–3.50 | 0.62 | 0.78 | 0.23–2.61 | 0.69 |
| Respiratory failure (%) | 1.9 | 3.4 | 0.54 | 0.16–1.82 | 0.33 | 0.34 | 0.07–1.67 | 0.18 |
| Pleural effusions/pneumothorax (%) | 1.9 | 4.6 | 0.40 | 0.14–1.14 | 0.09 | 0.36 | 0.10–1.22 | 0.10 |
| Sinus rhythm (%) | 94.2 | 96.2 | 0.63 | 0.26–1.53 | 0.31 | 1.25 | 0.44–3.54 | 0.66 |
| Atrial fibrillation (%) | 4.4 | 3.8 | 1.17 | 0.47–2.91 | 0.72 | 0.67 | 0.22–1.98 | 0.47 |
| MACCE (CVA/MI/mortality) (%) | 3.0 | 7.0 | 0.41 | 0.19–0.88 | 0.02 | 0.24 | 0.08–0.66 | 0.006 |
OR: odds ratio; CI 95%: confidence interval 95%; PAOR: propensity-adjusted OR; PA CI 95%: propensity-adjusted CI 95%; PA P-value: propensity-adjusted P-value; IABP: intra-aortic balloon pump; MACCE: major adverse cardiac and cerebrovascular events.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
